RR Rapaka, AS Cross, MA McArthur - Vaccines, 2021 - pubmed.ncbi.nlm.nih.gov
Using adjuvants to drive features of T cell responses to vaccine antigens is an important technological challenge in the design of new and improved vaccines against infections …
RR Rapaka, AS Cross, MA McArthur - Vaccines, 2021 - europepmc.org
Using adjuvants to drive features of T cell responses to vaccine antigens is an important technological challenge in the design of new and improved vaccines against infections …
AS Cross, MA McArthur - Vaccines, 2021 - search.proquest.com
Using adjuvants to drive features of T cell responses to vaccine antigens is an important technological challenge in the design of new and improved vaccines against infections …
RR Rapaka, AS Cross, MA McArthur - Vaccines, 2021 - ncbi.nlm.nih.gov
Using adjuvants to drive features of T cell responses to vaccine antigens is an important technological challenge in the design of new and improved vaccines against infections …
RR Rapaka, AS Cross, MA McArthur - Vaccines, 2021 - search.ebscohost.com
Using adjuvants to drive features of T cell responses to vaccine antigens is an important technological challenge in the design of new and improved vaccines against infections …
RR Rapaka, AS Cross, MA McArthur - Vaccines, 2021 - europepmc.org
Using adjuvants to drive features of T cell responses to vaccine antigens is an important technological challenge in the design of new and improved vaccines against infections …